Bone Mineral Content Continues to Increase in Obese Adolescents During W... ( PHILADELPHIA Feb. 1 -- Obese tee...)

Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss

Date:2/1/2008

PHILADELPHIA, Feb. 1 /PRNewswire-USNewswire/ -- Obese teenagers who succeeded in losing weight in a year-long medically supervised weight control program also saw their bone mineral content increase over that period, say researchers from The Children's Hospital of Philadelphia. The finding was reassuring, because adolescence is a critical period for bone health in later life.

A study in the current issue of the journal Obesity studied 62 adolescents between the ages of nine and 17 years who participated in a trial looking at the effectiveness of a comprehensive, family-based, behavioral weight control program in conjunction with a weight loss drug, sibutramine. The researchers previously reported the combination of behavioral changes and medication helped very obese teenagers lose weight.

In adults, obesity is associated with increased bone mineral density and voluntary weight loss is associated with a decrease in bone mineral density. The findings in this study show that bone mineral content continues to increase in this adolescent population despite weight loss.

"The growing pediatric obesity epidemic raises important clinical and public health questions about the effects on lifelong bone health of early onset obesity and its treatment," said Nicolas Stettler, M.D., M.S.C.E., pediatric nutrition specialist at The Children's Hospital of Philadelphia and lead author of this study. "Although fractures due to low bone mineral content are mainly a problem for the elderly, the amount of bone mass acquired during puberty is the key determinant of lifetime fracture risk."

Using a dual energy X-ray absorptiometry scanner (DXA), researchers looked at specific body areas including legs, arms and lumbar spine as well as the bone mineral content of the whole body. The data was compared with a reference group of 66 adolescents. Bone mineral content of the obese subjects was higher than that of the reference group at the beginning and e
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
2. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
3. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
4. Gilbert Hospital Continues Cutting Edge Treatments
5. Adult Smoking Rate Continues Downward Trend
6. Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
7. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
8. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
9. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
10. Superbug Outbreak Calls for Immediate Increased Attention on Infection Control
11. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model

Post Your Comments:

(Date:1/7/2009)...Puhua Hospital Stem Cells Center ( http://www.stem...em cells to effectively treat neurological disorde...dditions to its medical and research staff that si...lities for growing numbers of incoming internation...stinguished Dr. Jiang Ping, who was named Chief Sc...

(Date:1/6/2009)... -- The Michael J. Fox Foundation awarded a total ...ams for pre-clinical research on potential new tre...g was awarded under the Foundation,s Therapeutics...ched in 2006, supports and bolsters industry-focus...of MJFF,s focus on ,de-risking, preclinical PD r...

(Date:1/5/2009)... Pharmaceuticals announced today that it has initi...ein kinase inhibitor, CX-4945, in patients with ad...ple myeloma. The primary endpoints of the oral dos...lerance and PK properties of CX-4945 and to select...tion, multiple mechanism-related pharmacodynamic b...

(Date:12/29/2008)...swire/ -- The winner of the 2008 Award for Excelle...ay by Dr. Peter G. Goldschmidt, President and Foun...he winner of the annual award was the Universit...ts best practice " IND Regulatory and Monitoring P...man subjects protection, 2) improved data quality ...

[0] Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients [0] Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research [3] Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 [0] 2008 Human Research Protection Award Recipients Announced

...rstCall/--,EntreMed, Inc. , a clinical-stage pharm...treatment of cancer and inflammatory diseases,tod...ts for MKC-1,its novel cell cycle inhibitor. The ...American Association for Cancer Research (AACR),An...California. , MKC-1 is a novel, orally-active cell...

...ansurethral Resection,is Well Tolerated in Phase 2...2007 /PRNewswire-FirstCall/ --,Spectrum Pharmaceut... study of EOquin, in non-invasive bladder cancer a...L)-1620 and satraplatin,at the annual meeting of t...t the Los Angeles Convention Center in Los Angeles...

Other Medicine Technology:EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 2 EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 3 EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 4 Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 2 Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 3 Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 4 Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 5 Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 6 Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 7 Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 8

EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting

(Date:1/8/2009)...wswire-FirstCall/ -- Allscripts-Misys Healthcare,...lutions, Inc. (Allscripts or,the Company), today ...six,months ended November 30, 2008. , (Log...LLSCRIPTSLOGO-b ) , The Company,s results f...8,include results from legacy Allscripts for the ...

(Date:1/8/2009)...RNewswire-USNewswire/ -- A new educational Web sit...on drugs, biological products and medical devices ...y,s Centers for Education and Research on Therapeu...e than a dozen leading research centers nationwide...ion Network ( CHAIN ) http://www.chainonline.org ...

(Date:1/8/2009)...PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq..., , What: Heska Corporation Invites You to...nd 2008 Earnings Conference Call on the Web, ...], Where: www.heska.com (click on the Q4 ...k on the front page of this website)., How: ...

(Date:1/8/2009)...sile Strikes , , NEW YORK, Jan. 8 /PRNewswire-... the Jewish Federations of North America today com...n and social needs in southern Israel, part of a m... with Israelis during the current conflict with Ha...Gaza Strip. , , The funds will enhance program...

[0] Allscripts Reports Fiscal 2009 Second Quarter Results [0] AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics [0] Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast [0] UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel

...ia were diagnosed with severe symptoms of cholera.... prison are hospitalized after they showed symptom...Doctors, health officials and the prison officials...result in a cholera endemic. Cholera is a water b...

... is a significant reduction in the case of cardiov...both in the case of men and women. In the case of ...while in the case of women, the possibilities of s...role of aspirin in bringing down such risks are no...

...was arrested after the death of her patient. Dr S...last Friday and was released on bail. // She had b...ondon. Dr Dhar was arrested and was charged for ma...e and depraving the course of justice. Her patien...

...ery upset and has sent a letter to the acting head...on Eschenbach. In his letter he had asked the FDA ...onfusion started when it was reveled that the tain...n case of tissue transplants. Schumer asked the fe...

Other Medicine News:

Cholera sneaks its way in to the prison Aspirin Serves To Reduce Cardiovascular Events Bail Granted To The Doctor Despite Her Patient's Death FDA needs to be more vigilant in monitoring, tissue banks.

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base.

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base.

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base.

Medicine Products:

4V61 4V42 4V41-R 4V41

Bone Mineral Content Continues to Increase in Obese Adolescents During W...( PHILADELPHIA Feb. 1 -- Obese tee...),Health